Furthermore, PDX (patient–derived tumor xenograft) model experiment showed that NZ001 had a significant inhibitory effect on tumor growth of HCC with MET-amplification and MET-overexpression, and also prolonged the survival of mice (Fig. 7e, f). This evidence concerns the gene MET and hepatocellular carcinoma.